14-94314305-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001756.4(SERPINA6):c.344T>A(p.Leu115His) variant causes a missense change. The variant allele was found at a frequency of 0.00246 in 1,614,130 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 2 hom. )
Consequence
SERPINA6
NM_001756.4 missense
NM_001756.4 missense
Scores
1
9
8
Clinical Significance
Conservation
PhyloP100: 5.41
Genes affected
SERPINA6 (HGNC:1540): (serpin family A member 6) This gene encodes an alpha-globulin protein with corticosteroid-binding properties. This is the major transport protein for glucorticoids and progestins in the blood of most vertebrates. The gene localizes to a chromosomal region containing several closely related serine protease inhibitors which may have evolved by duplication events. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014943153).
BS2
High Homozygotes in GnomAdExome4 at 2 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINA6 | NM_001756.4 | c.344T>A | p.Leu115His | missense_variant | 2/5 | ENST00000341584.4 | NP_001747.3 | |
SERPINA6 | XM_047431827.1 | c.344T>A | p.Leu115His | missense_variant | 2/5 | XP_047287783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINA6 | ENST00000341584.4 | c.344T>A | p.Leu115His | missense_variant | 2/5 | 1 | NM_001756.4 | ENSP00000342850.3 | ||
SERPINA6 | ENST00000557225.1 | c.344T>A | p.Leu115His | missense_variant | 2/2 | 2 | ENSP00000452018.1 | |||
SERPINA6 | ENST00000555056.1 | n.344T>A | non_coding_transcript_exon_variant | 2/5 | 2 | ENSP00000451045.1 |
Frequencies
GnomAD3 genomes AF: 0.00218 AC: 332AN: 152122Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
332
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00223 AC: 560AN: 251354Hom.: 0 AF XY: 0.00244 AC XY: 332AN XY: 135842
GnomAD3 exomes
AF:
AC:
560
AN:
251354
Hom.:
AF XY:
AC XY:
332
AN XY:
135842
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00249 AC: 3638AN: 1461890Hom.: 2 Cov.: 32 AF XY: 0.00246 AC XY: 1786AN XY: 727246
GnomAD4 exome
AF:
AC:
3638
AN:
1461890
Hom.:
Cov.:
32
AF XY:
AC XY:
1786
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00218 AC: 332AN: 152240Hom.: 1 Cov.: 32 AF XY: 0.00226 AC XY: 168AN XY: 74432
GnomAD4 genome
AF:
AC:
332
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
168
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
22
ExAC
AF:
AC:
268
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 14, 2024 | Observed in the homozygous state or with an additional SERPINA6 variant in patients with decreased cortisol-binding activity, but has not been described in association with frank CBG deficiency (PMID: 1504007, 7061486); Published functional studies demonstrate a damaging effect with reduced cortisol binding affinity (PMID: 1504007); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as L93H and CBG Leuven using alternate nomenclature; This variant is associated with the following publications: (PMID: 7061486, 1504007, 8212073, 22013108, 25010111, 30409984, 34308089, 27113851, 36681594) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2019 | - - |
Corticosteroid-binding globulin deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1993 | - - |
SERPINA6-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 07, 2023 | The SERPINA6 c.344T>A variant is predicted to result in the amino acid substitution p.Leu115His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.34% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 10, 2024 | Variant summary: SERPINA6 c.344T>A (p.Leu115His) results in a non-conservative amino acid change located in the Serpin domain (IPR023796) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0022 in 251354 control chromosomes, predominantly at a frequency of 0.0033 within the Non-Finnish European subpopulation in the gnomAD database, strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.344T>A has been reported in the literature in one individual affected with multiple diseases including diabetes mellitus, coronary artery disease, hypertension, osteoarthritis, gastric erosions secondary to the use of nonsteroidal anti-inflammatory drugs, septic shock and acute respiratory failure (Smith_1992). These report(s) do not provide unequivocal conclusions about association of the variant with Corticosteroid-Binding Globulin Deficiency. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in >50%-90% of normal steroid binding capacity in Chinese hamster ovary cells (Smith_1992). The following publication has been ascertained in the context of this evaluation (PMID: 1504007). ClinVar contains an entry for this variant (Variation ID: 16974). Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Uncertain
D;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;.
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at